The blend delivers 330 mcg per day (2,310 mcg per week on a 7-day schedule), which aligns with the lower end of maintenance dosing
Mastrocola R, Aragno M, Alloatti G, Collino M, Penna C, Pagliaro P
A phase I/II clinical trial found that the most common side effects were mild and transient (Teichman et al., 2006): Injection site reactions (redness, mild swelling) Headaches Flushing or warmth Temporary water retention Joint tightness or tingling Transient fatigue or dizziness Serious adverse events are rare when the peptide is used under medical supervision at appropriate doses
J Crop Sci Biotechnol 22:253264 Santos CS, Ozgur R, Uzilday B, Turkan I, Roriz M, Rangel AOSS, Carvalho SMP, Vasconcelos MW (2019b) Understanding the role of the antioxidant system and the tetrapyrrole cycle in iron deficiency chlorosis
It supports emotional regulation without pressure